A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer
- Cancer
- Breast Cancer
Completed
- Buenos Aires
- HPR
- Rosario
- San Miguel de Tucumán
NCT02761616 ML30038
Trial Summary
This is a retrospective, and observational cohort study to determine the proportion of breast cancer first relapses, that are biopsied. The duration of the study will be approximately 24 months.
Eligibility Criteria
- Participants with histologically confirmed breast cancer treated for early breast cancer (eBC) with first metastatic relapse disease in the period from January 1, 2014 and December 31, 2015
Not Applicable
For the latest version of this information please go to www.forpatients.roche.com